How much is a box of domestic crizotinib?

How much is a box of domestic crizotinib?
Lung cancer is one of the most common malignant tumors globally and also one of the most common causes of death. According to statistics, there are more than 2 million new lung cancer patients worldwide every year. Although the incidence and mortality rates of lung cancer have decreased in recent years, it remains a major challenge to health. Especially for those patients with advanced and metastatic lung cancer, crizotinib has brought new treatment options for them.
The research and development of crizotinib has received unanimous praise and is recognized as an important breakthrough in the field of special treatment for lung cancer. This drug mainly acts on specific genetic alterations in lung cancer, such as the fusion genes Anaplastic Lymphoma Kinase (ALK), c-ros oncogene 1 (ROS1), and Rearranged During Transfection (RET). The fusion of these genes can lead to abnormal cell division and proliferation, thus triggering lung cancer. Crizotinib inhibits the activity of these abnormal kinases, preventing the growth and spread of tumors.
Affordability and good quality are major characteristics of domestic crizotinib. Compared with imported drugs, the price of domestic crizotinib is relatively low, usually between 1,000 and 2,000 yuan per box. Although this price is still expensive for ordinary people, it has obvious advantages compared with imported drugs. This enables more lung cancer patients to afford the drug and benefit from it.
It is worth noting that a low price does not mean low quality. The development of domestic crizotinib has undergone strict quality control and testing to ensure the efficacy and safety of the drug. Domestic pharmaceutical companies have optimized the production process, improved the purity of the drug, and taken other improvement measures to increase its stability. Compared with imported drugs, its quality and effectiveness are not inferior.
However, when purchasing domestic crizotinib, the following aspects still need to be noted. Firstly, check whether the drug has been approved by the national drug regulatory authorities. Secondly, when purchasing drugs, choose reputable hospitals or pharmacies to avoid buying inferior products. Finally, during the use of the drug, patients should closely monitor their physical reactions and communicate with their doctors in a timely manner to make corresponding adjustments and monitoring.
The advent of crizotinib has brought new hope to lung cancer patients. As a relatively inexpensive and effective drug, it provides treatment opportunities for more patients. However, although the price of domestic crizotinib is relatively low, there is still a certain financial burden. Therefore, we should strengthen the formulation of relevant policies to reduce the price of the drug and provide help for more patients in need